The Coulter Network is a select group of biomedical engineering programs across the United States that follow a proven methodology to translate life science technologies from university research into commercial products. Biolocity is based on this translational process which utilizes best practices from industry to accelerate academic innovations to the market.
To learn more about the Coulter Network, use the links below to view each university’s program and its available technologies.
Phase 1 Programs
Phase one programs were the original universities selected to receive funding by the Wallace H. Coulter Foundation and to pioneer the Coulter Program on campus. Biolocity’s pilot program was stewarded by the Biomedical Engineering Department at Emory University and the Georgia Institute of Technology and founded to bridge the gap in early-stage technologies emanating from both universities.
- Case Western Reserve University (Cleveland, OH) – Available technologies
- Drexel University (Philadelphia, PA) – Available technologies
- Duke University (Durham, NC) – Available technologies
- Georgia Institute of Technology/Emory University (Atlanta, GA) – Available technologies
- Stanford University (Stanford, CA) – Available technologies
- University of Michigan (Ann Arbor, MI)
- University of Virginia (Charlottesville, VA) – Available technologies
Phase 2 Programs
Based on the success of phase one, the below universities were selected for funding and expansion of the Coulter Program.
- Columbia University (New York City, NY) – Available technologies
- Johns Hopkins University (Baltimore, MD)
- University of Louisville (Louisville, KY) – Available technologies
- University of Miami (Miami, FL)
- University of Missouri (Columbia, MO) – Available technologies
- University of Pittsburgh (Pittsburgh, PA)
- University of Southern California (Los Angeles, CA)